PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancer

Autor: Post, Cathalijne C.B. *, Westermann, Anneke M., Bosse, Tjalling, Creutzberg, Carien L., Kroep, Judith R.
Zdroj: In Critical Reviews in Oncology / Hematology August 2020 152
Databáze: ScienceDirect